| Description | SKLB-23bbisanorallybioavailableHDAC6-selectiveinhibitorwithIC50valuesunder100nmol/L,againstmostofthecelllineschecked.Italsohasmicrotubule-disruptingABIlity. | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Targets |
| ||||||||||||||
| Invitro | SKLB-23bbshowscytotoxiceffectsagainstapanelofsolidandhematologictumorcelllinesatthelowsubmicromolarlevel.IncontrasttothereportedHDAC6-selectiveinhibitors,SKLB-23bbismoreefficientagainstsolidtumorcells.SKLB-23bbselectivelyinhibitscellularHDAC6,buttheantitumoractivityofSKLB-23bbisindependentofHDAC6.SKLB-23bbcouldbindtothecolchicinesiteinβ-tubulinandactasamicrotubulepolymerizationinhibitor.ItblockstumorcellcycleatG2-Mphaseandtriggerscellularapoptosis[1]. | ||||||||||||||
| Assay |
|

